ANXA2 expression in African American triple-negative breast cancer patients

Lee D. Gibbs, Pankaj Chaudhary, Kelsey Mansheim, Richard J. Hare, Rebecca A. Mantsch, Jamboor K. Vishwanatha

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Purpose: Our aim was to determine the role of Annexin A2 (AnxA2), which we have previously found to contribute to the aggressiveness of TNBC, with AA TNBC patients and clinical outcome. Methods: We analyzed TCGA breast cancer database (n = 1098) to observe AnxA2 expression within breast cancer subtypes and is correlation with overall survival. Further, we examined breast tissue specimens (n = 119) through chromogenic in situ hybridization (CISH) and specimen were scored independently by two pathologists in a blinded study. Results: In our TCGA analysis, high expression of AnxA2 was correlated with poor survival in patients with TNBC. AnxA2 gene expression was not correlated with poor survival in other breast cancer subtypes. AnxA2 average CISH intensity score (CISH score = 0, null expression to 3, high expression) for TNBC was significantly higher in comparison to estrogen receptor and/or progesterone receptor positive, human epidermal growth factor positive, and non-malignant tissues. Furthermore, AnxA2 average score was significantly higher in AA TNBC patients (CISH average score = 2.45 ± 0.3266) in comparison to Caucasian TNBC patients (CISH average score = 1.1 ± 0.4069). Conclusion: AnxA2 is overexpressed in TNBC, implicating AnxA2 as a contributor to the aggressive biology of TNBC in AA women.

Original languageEnglish
Pages (from-to)113-120
Number of pages8
JournalBreast Cancer Research and Treatment
Volume174
Issue number1
DOIs
StatePublished - 28 Feb 2019

Fingerprint

Annexin A2
Triple Negative Breast Neoplasms
African Americans
In Situ Hybridization
Breast Neoplasms
Survival
Annexins
Progesterone Receptors
Epidermal Growth Factor
Estrogen Receptors
Breast
Databases
Gene Expression

Keywords

  • African American
  • Annexin A2
  • Biomarker
  • Prognosis
  • Triple-negative breast cancer

Cite this

Gibbs, Lee D. ; Chaudhary, Pankaj ; Mansheim, Kelsey ; Hare, Richard J. ; Mantsch, Rebecca A. ; Vishwanatha, Jamboor K. / ANXA2 expression in African American triple-negative breast cancer patients. In: Breast Cancer Research and Treatment. 2019 ; Vol. 174, No. 1. pp. 113-120.
@article{54849c27a3bb4f31ac23dc110288d456,
title = "ANXA2 expression in African American triple-negative breast cancer patients",
abstract = "Purpose: Our aim was to determine the role of Annexin A2 (AnxA2), which we have previously found to contribute to the aggressiveness of TNBC, with AA TNBC patients and clinical outcome. Methods: We analyzed TCGA breast cancer database (n = 1098) to observe AnxA2 expression within breast cancer subtypes and is correlation with overall survival. Further, we examined breast tissue specimens (n = 119) through chromogenic in situ hybridization (CISH) and specimen were scored independently by two pathologists in a blinded study. Results: In our TCGA analysis, high expression of AnxA2 was correlated with poor survival in patients with TNBC. AnxA2 gene expression was not correlated with poor survival in other breast cancer subtypes. AnxA2 average CISH intensity score (CISH score = 0, null expression to 3, high expression) for TNBC was significantly higher in comparison to estrogen receptor and/or progesterone receptor positive, human epidermal growth factor positive, and non-malignant tissues. Furthermore, AnxA2 average score was significantly higher in AA TNBC patients (CISH average score = 2.45 ± 0.3266) in comparison to Caucasian TNBC patients (CISH average score = 1.1 ± 0.4069). Conclusion: AnxA2 is overexpressed in TNBC, implicating AnxA2 as a contributor to the aggressive biology of TNBC in AA women.",
keywords = "African American, Annexin A2, Biomarker, Prognosis, Triple-negative breast cancer",
author = "Gibbs, {Lee D.} and Pankaj Chaudhary and Kelsey Mansheim and Hare, {Richard J.} and Mantsch, {Rebecca A.} and Vishwanatha, {Jamboor K.}",
year = "2019",
month = "2",
day = "28",
doi = "10.1007/s10549-018-5030-5",
language = "English",
volume = "174",
pages = "113--120",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

ANXA2 expression in African American triple-negative breast cancer patients. / Gibbs, Lee D.; Chaudhary, Pankaj; Mansheim, Kelsey; Hare, Richard J.; Mantsch, Rebecca A.; Vishwanatha, Jamboor K.

In: Breast Cancer Research and Treatment, Vol. 174, No. 1, 28.02.2019, p. 113-120.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - ANXA2 expression in African American triple-negative breast cancer patients

AU - Gibbs, Lee D.

AU - Chaudhary, Pankaj

AU - Mansheim, Kelsey

AU - Hare, Richard J.

AU - Mantsch, Rebecca A.

AU - Vishwanatha, Jamboor K.

PY - 2019/2/28

Y1 - 2019/2/28

N2 - Purpose: Our aim was to determine the role of Annexin A2 (AnxA2), which we have previously found to contribute to the aggressiveness of TNBC, with AA TNBC patients and clinical outcome. Methods: We analyzed TCGA breast cancer database (n = 1098) to observe AnxA2 expression within breast cancer subtypes and is correlation with overall survival. Further, we examined breast tissue specimens (n = 119) through chromogenic in situ hybridization (CISH) and specimen were scored independently by two pathologists in a blinded study. Results: In our TCGA analysis, high expression of AnxA2 was correlated with poor survival in patients with TNBC. AnxA2 gene expression was not correlated with poor survival in other breast cancer subtypes. AnxA2 average CISH intensity score (CISH score = 0, null expression to 3, high expression) for TNBC was significantly higher in comparison to estrogen receptor and/or progesterone receptor positive, human epidermal growth factor positive, and non-malignant tissues. Furthermore, AnxA2 average score was significantly higher in AA TNBC patients (CISH average score = 2.45 ± 0.3266) in comparison to Caucasian TNBC patients (CISH average score = 1.1 ± 0.4069). Conclusion: AnxA2 is overexpressed in TNBC, implicating AnxA2 as a contributor to the aggressive biology of TNBC in AA women.

AB - Purpose: Our aim was to determine the role of Annexin A2 (AnxA2), which we have previously found to contribute to the aggressiveness of TNBC, with AA TNBC patients and clinical outcome. Methods: We analyzed TCGA breast cancer database (n = 1098) to observe AnxA2 expression within breast cancer subtypes and is correlation with overall survival. Further, we examined breast tissue specimens (n = 119) through chromogenic in situ hybridization (CISH) and specimen were scored independently by two pathologists in a blinded study. Results: In our TCGA analysis, high expression of AnxA2 was correlated with poor survival in patients with TNBC. AnxA2 gene expression was not correlated with poor survival in other breast cancer subtypes. AnxA2 average CISH intensity score (CISH score = 0, null expression to 3, high expression) for TNBC was significantly higher in comparison to estrogen receptor and/or progesterone receptor positive, human epidermal growth factor positive, and non-malignant tissues. Furthermore, AnxA2 average score was significantly higher in AA TNBC patients (CISH average score = 2.45 ± 0.3266) in comparison to Caucasian TNBC patients (CISH average score = 1.1 ± 0.4069). Conclusion: AnxA2 is overexpressed in TNBC, implicating AnxA2 as a contributor to the aggressive biology of TNBC in AA women.

KW - African American

KW - Annexin A2

KW - Biomarker

KW - Prognosis

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=85057333711&partnerID=8YFLogxK

U2 - 10.1007/s10549-018-5030-5

DO - 10.1007/s10549-018-5030-5

M3 - Article

VL - 174

SP - 113

EP - 120

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -